Altum Pharmaceuticals
  • About
    • History
    • Board of Directors
    • Management
    • Advisors
  • Disease Areas & Unmet Need
    • Cervical Dysplasia/Cancer and Human Papilloma Virus (HPV)
    • Cancer Bone Metastases & Skeletal Related Events
  • Pipeline
    • Pipeline Overview
    • AP-001
    • AP-002
    • BiPhasix™ Platform
  • News & Events
  • Contact
Select Page

Altum Pharma Appoints New Executive Chair of the Board of Directors

by Altm-admn | Oct 8, 2018 | Altum, Altum Pharmaceuticals, Business

VANCOUVER, September 16, 2018  – Altum Pharmaceuticals Inc. (“Altum” or “Altum Pharmaceuticals”) a biopharmaceutical company focused on the development of innovative therapeutic products is pleased to announce the appointment of Ms. Nancy...

Recent Posts

  • Altum Pharma Appoints New Executive Chair of the Board of Directors
  • Altum Pharmaceuticals, Inc. completes acquisition of Lexi Pharma Inc, and its pipeline of novel therapies for bone disease and oncology
  • Altum Signs Exclusive Worldwide License Agreement
  • Altum Pharmaceuticals Enters into Agreement with Ortac Capital & Ortac AG

Archives

  • October 2018
  • April 2018
  • March 2017
  • June 2016
  • Privacy
  • Terms of Use
  • Cookie Policy
  • English
  • German
© 2020 Altum Pharmaceuticals Inc. All rights reserved.
We use cookies, including 3rd party cookies (e.g. Google, LinkedIn) to improve your experience on our website, analyse our traffic. By continuing to use this website, you accept our cookie policy.AcceptCookie policy